SMO and pachyonychia congenita: PTCH actively suppresses the pathway by inhibiting SMO; nevertheless, the binding of SHh, a secreted Hh ligand which is abnormally expressed in over 70% of PC, to PTCH prevents SMO inhibition, leading to the activation of the pathway [79].